newsfilter
← Latest News
Business Wire·

Alpine Immune Sciences to Report Third Quarter 2022 Financial Results

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the company will release